Japan Health Ministry committee approves Pfizer oral COVID-19 drug

A Japanese Health Ministry committee has approved the oral COVID-19 drug made by U.S. drugmaker Pfizer Inc, the ministry said in a statement on Friday.

Jiji news agency said final approval of the drug for use, which officials had said they expected would come around mid-February, could come as early as Friday night under emergency approval measures.

Pfizer applied for approval in January.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)